Brittany McLaughlin

Brittany McLaughlin, CCRP, is an experienced professional in clinical operations, currently serving as Associate Director at Alnylam Pharmaceuticals since January 2019, having progressed through roles including Senior Manager and Manager in the same department. Prior experience includes working as a Clinical Project Manager at Proteostasis Therapeutics, Inc. and a Senior Associate in Clinical Operations at Sarepta Therapeutics. Previous roles also encompass positions at Premier Research Group as a Clinical Trial Associate and at Brigham and Women's Hospital within the TIMI Study Group as a Clinical Trial Protocol Coordinator. Brittany McLaughlin earned a Bachelor's degree in Mathematics and Actuarial Science from the University of Connecticut in 2010.